| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d31071e537d12752cb5e4a7d937cbdd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2001-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a3fc207349d54c1ea9f1728f692c42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92a91aa1d16cff570de7440911b8dfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb78b70ad918038e87dc47254635352 |
| publicationDate |
2003-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-0300477-A2 |
| titleOfInvention |
Use of preparations containing PDE5 inhibitors for the daily treatment of erectile dysfunction |
| abstract |
The present invention relates to phosphodiesterase (PDE) enzyme inhibitors and their use in pharmaceutical compositions. The present invention relates in particular to potent inhibitors of cyclic guanosine-3 ', 5'-monophosphate-specific phosphodiesterase type 5 (PDE5), which can be used as part of a pharmaceutical composition in a dosage range of about 1 mg to about 10 mg per day. to treat disorders. The compositions of the present invention are characterized by their inhibition of PDE5 enzyme function and may therefore be useful in all therapeutic areas where PDE5 inhibition may be beneficial, particularly in erectile dysfunction, while the other phosphodiesterase enzyme inhibition side effects are vascular condition improves. HE |
| priorityDate |
2000-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |